131 – 140 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
(
- Contribution to journal › Article
-
Mark
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hk2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
(
- Contribution to journal › Article
- 2005
-
Mark
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
(
- Contribution to journal › Article
-
Mark
Translational crossroads for biomarkers
(
- Contribution to journal › Article
- 2004
-
Mark
Lead time associated with screening for prostate cancer
(
- Contribution to journal › Article
-
Mark
Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
(
- Contribution to journal › Article
- 2003
-
Mark
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues
(
- Contribution to journal › Article
- 2002
-
Mark
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer
(
- Contribution to journal › Article